C21 Investments Inc. (CSE:CXXI)
0.3750
-0.0300 (-7.41%)
Apr 10, 2026, 3:56 PM EST
C21 Investments Market Cap
C21 Investments has a market cap or net worth of CAD 44.21 million as of April 10, 2026. Its market cap has increased by 74.28% in one year.
Market Cap
44.21M
Enterprise Value
55.91M
Revenue
45.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.38
Market Cap Chart
Since September 7, 1988, C21 Investments's market cap has increased from 7.93M to 44.21M, an increase of 457.64%. That is a compound annual growth rate of 4.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 44.21M | -29.29% |
| Dec 31, 2025 | 62.53M | 79.60% |
| Dec 31, 2024 | 34.81M | -9.38% |
| Dec 29, 2023 | 38.42M | 23.08% |
| Dec 30, 2022 | 31.21M | -58.93% |
| Dec 31, 2021 | 76.00M | -60.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioNxt Solutions | 68.66M |
| Vext Science | 65.27M |
| Planet 13 Holdings | 64.01M |
| Leef Brands | 55.88M |
| LSL Pharma Group | 46.67M |
| ZYUS Life Sciences | 45.90M |
| iAnthus Capital Holdings | 34.86M |
| Rubicon Organics | 33.79M |